Introduction The sarilumab market has emerged as a high-growth segment within autoimmune therapy, accelerating due to rising prevalence of rheumatoid arthritis (RA) and expanding biologic adoption. Its development as a…
Introduction The sarilumab market has emerged as a high-growth segment within autoimmune therapy, accelerating due to rising prevalence of rheumatoid arthritis (RA) and expanding biologic adoption. Its development as a…